MARKSANS — Marksans Pharma Share News
0.000.00%
Last trade - 00:00- IN₹130.01bn
- IN₹123.80bn
- IN₹29.51bn
Brief: Marksans Pharma Reports March-Quarter Consol Net Profit Of 905.5 Million Rupees
Brief: Marksans Pharma Facility In Goa Approved By Australian TGA
India's Marksans Pharma rises with Australian market entry
Brief: Marksans Pharma Says Relonchem Receives UK MHRA approval For Baclofen 10 mg Tablets
India's Marksans Pharma up on UK nod for drug to treat muscle spasms
Uk Unit Gets Marketing Authorization For Product Ibuprofen And Paracetamol
Brief: Marksans Pharma Dec-Quarter Consol Net Profit 1.05 Billion Rupees
Brief: Marksans Pharma Gets USFDA Approval For Loratadine USP 10Mg Tablets
Brief: Marksans Pharma Sept-Quarter Consol Net Profit 967.2 Million Rupees
Brief: Marksans Pharma Unit Relonchem Gets Marketing Authorization For Its Products
India's Marksans Pharma up as US FDA closes inspection of Goa facility
Brief: Marksans Pharma Announces Closure Of FDA Inspection At Manufacturing Facility In Goa
India's Marksans Pharma rises after Q1 profit boost
Brief: Marksans Pharma June-Quarter Consol Net Profit 887.5 Million Rupees
India's Marksans Pharma up as unit gets nod from UK drug regulator
Brief: Marksans Pharma says Unit Relonchem Gets Marketing Authorization From UKMHRA
India's Marksans Pharma set for worst day in 4 years as profit drops
Brief: Marksans Pharma March-Qtr Consol Net Profit Falls
India's Marksans Pharma up on UK regulator nod for unit's seizure drug